Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ONXX -- Ignore unavailable to you. Want to Upgrade?

To: Elmer who wrote (704)	11/28/2000 5:28:05 PM
From: scaram(o)uche	Respond to of 810

OT "worth owning" It's always a matter of how much you have to pay. I can't flip IPOs, and I don't feel like playing the "shares, shares, who has the shares" shell game that has characterized the biotech aftermarket for years. I like a lot of the "phenotyping" companies, but I'm not willing to pay even top-of-range prices, much less those that are often achieved in short order. Love SGMO, the company. Hated SGMO, the stock. Love LEXG, the company. Hated, LEXG the stock. Waited for it to come down and bought some. Hate LEXG, the stock, even more than before. <g>